Does thrombolysis in myocardial infarction (TIMI) perfusion grade 2 represent a mostly patent artery or a mostly occluded artery? Enzymatic and electrocardiographic evidence from the TEAM-2 study. Second Multicenter Thrombolysis Trial of Eminase in Acute Myocardial Infarction

Department of Medicine, University of Utah, Salt Lake City.

One measure of the success of thrombolysis is the early patency status of the infarct-related coronary artery. The Thrombolysis in Myocardial Infarction (TIMI) study group designated patency grades 0 (occluded) or 1 (minimal perfusion) as thrombolysis failure and grade 2 (partial perfusion) or 3 (complete perfusion) as success. To evaluate their true functional significance, perfusion grades were compared with enzymatic and electrocardiographic (ECG) indexes of myocardial infarction in 359 patients treated within 4 h with anistreplase (APSAC) or streptokinase. Serum enzymes and ECGs were assessed serially. Patency was determined at 90 to 240 min (median 2.1 h) and graded by an observer who had no knowledge of patient data. Results for the two drug arms were similar and combined. Distribution of patency was grade 0 = 20%, n = 72; grade 1 = 8% n = 27; grade 2 = 16%, n = 58 and grade 3 = 56%, n = 202. Interventions were performed after angiography but within 24 h in 51% (n = 37), 70% (n = 19), 41% (n = 24) and 14% (n = 28) of patients with grades 0, 1, 2 and 3, respectively. Outcomes were compared among the four patency groups by the orthogonal contrast method. Patients with perfusion grade 2 did not differ significantly from those with grade 0 or 1 in enzymatic peaks, time to peak activity and evolution of summed ST segments, Q waves and R waves (contrast 2). Conversely, comparisons of patients with grade 3 perfusion with those with grades 0 to 2 yielded significant differences for enzymatic peaks and time to peak activity for three of the four enzymes (p = 0.02 to 0.0001) and ECG indexes of myocardial infarction (p = 0.02 to 0.0001) (contrast 3). Thus, patients with grade 2 flow have indexes of myocardial infarction similar to those in patients with an occluded artery (grades 0 and 1 flow). Only early grade 3 flow results in a significantly better outcome than that of the other grades. Because early achievement of grade 2 flow does not appear to lead to optimal myocardial salvage, the frequency of achieving grade 3 perfusion alone may best measure the reperfusion success of thrombolytic therapy.

This article has been cited by other articles:

				Y. Kawai, K. Hisamatsu, H. Matsubara, K. Dan, S. Akagi, K. Miyaji, M. Munemasa, Y. Fujimoto, K. F. Kusano, and T. Ohe Intravenous administration of nicorandil immediately before percutaneous coronary intervention can prevent slow coronary flow phenomenon Eur. Heart J., April 1, 2009; 30(7): 765 - 772. [Abstract] [Full Text] [PDF]

				G. Ndrepepa, J. Mehilli, S. Schulz, R. Iijima, D. Keta, R. A. Byrne, J. Pache, M. Seyfarth, A. Schomig, and A. Kastrati Prognostic Significance of Epicardial Blood Flow Before and After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndromes J. Am. Coll. Cardiol., August 12, 2008; 52(7): 512 - 517. [Abstract] [Full Text] [PDF]

				G. Heper, M. E. Korkmaz, and A. Kilic Reperfusion Arrhythmias: Are They Only a Marker of Epicardial Reperfusion or Continuing Myocardial Ischemia After Acute Myocardial Infarction? Angiology, January 1, 2008; 58(6): 663 - 670. [Abstract] [PDF]

				H. Sato, H. Iida, A. Tanaka, H. Tanaka, S. Shimodouzono, E. Uchida, T. Kawarabayashi, and J. Yoshikawa The decrease of plaque volume during percutaneous coronary intervention has a negative impact on coronary flow in acute myocardial infarction: A major role of percutaneous coronary intervention-induced embolization J. Am. Coll. Cardiol., July 21, 2004; 44(2): 300 - 304. [Abstract] [Full Text] [PDF]

				S. Hamada, T. Nishiue, S. Nakamura, T. Sugiura, H. Kamihata, H. Miyoshi, Y. Imuro, and T. Iwasaka TIMI frame count immediately after primary coronary angioplasty as a predictor of functional recovery in patients with TIMI 3 reperfused acute myocardial infarction J. Am. Coll. Cardiol., September 1, 2001; 38(3): 666 - 671. [Abstract] [Full Text] [PDF]

				K G OLDROYD Identifying failure to achieve complete (TIMI 3) reperfusion following thrombolytic treatment: how to do it, when to do it, and why it's worth doing Heart, August 1, 2000; 84(2): 113 - 115. [Full Text] [PDF]

				A G C Sutton, P G Campbell, E D Grech, D J A Price, A Davies, J A Hall, M J Stewart, and M A de Belder Failure of thrombolysis: experience with a policy of early angiography and rescue angioplasty for electrocardiographic evidence of failed thrombolysis Heart, August 1, 2000; 84(2): 197 - 204. [Abstract] [Full Text] [PDF]

				L. E. Goldman and M. J. Eisenberg Identification and Management of Patients with Failed Thrombolysis after Acute Myocardial Infarction Ann Intern Med, April 4, 2000; 132(7): 556 - 565. [Abstract] [Full Text] [PDF]

				A. Shah, G. S. Wagner, C. B. Granger, C. M. O'Connor, C. L. Green, K. M. Trollinger, R. M. Califf, and M. W. Krucoff Prognostic implications of TIMI flow grade in the infarct related artery compared with continuous 12-lead ST-segment resolution analysis: Reexamining the "gold standard" for myocardial reperfusion assessment J. Am. Coll. Cardiol., March 1, 2000; 35(3): 666 - 672. [Abstract] [Full Text] [PDF]

				T. Kawamoto, K. Yoshida, T. Akasaka, T. Hozumi, T. Takagi, S. Kaji, and Y. Ueda Can Coronary Blood Flow Velocity Pattern After Primary Percutaneous Transluminal Coronary Angiography Predict Recovery of Regional Left Ventricular Function in Patients With Acute Myocardial Infarction? Circulation, July 27, 1999; 100(4): 339 - 345. [Abstract] [Full Text] [PDF]

				F Leclercq, P Messner-Pellenc, Q Descours, J-P Daures, J-L Pasquie, F-X Hager, J-M Davy, and R Grolleau-Raoux Combined assessment of reflow and collateral blood flow by myocardial contrast echocardiography after acute reperfused myocardial infarction Heart, July 1, 1999; 82(1): 62 - 67. [Abstract] [Full Text] [PDF]

				G. Frostfeldt, G. Ahlberg, G. Gustafsson, G. Helmius, B. Lindahl, A. Nygren, A. Siegbahn, E. Swahn, P. Venge, and L. Wallentin Low molecular weight heparin (dalteparin) as adjuvant treatment to thrombolysis in acute myocardial infarction--a pilot study: Biochemical Markers in Acute Coronary Syndromes (BIOMACS II) J. Am. Coll. Cardiol., March 1, 1999; 33(3): 627 - 633. [Abstract] [Full Text] [PDF]

				C. M. Nunn, W. W. O'Neill, D. Rothbaum, G. W. Stone, J. O'Keefe, P. Overlie, B. Donohue, L. Grines, K. F. Browne, R. E. Vlietstra, et al. Long-term outcome after primary angioplasty: report from the Primary Angioplasty in Myocardial Infarction (PAMI-I) trial J. Am. Coll. Cardiol., March 1, 1999; 33(3): 640 - 646. [Abstract] [Full Text] [PDF]

				G. L. Reed and A. K. Houng The Contribution of Activated Factor XIII to Fibrinolytic Resistance in Experimental Pulmonary Embolism Circulation, January 19, 1999; 99(2): 299 - 304. [Abstract] [Full Text] [PDF]

				R. A. Phillips, L. R. Krakoff, A. Dunaif, D. T. Finegood, R. Gorlin, and S. Shimabukuro Relation among Left Ventricular Mass, Insulin Resistance, and Blood Pressure in Nonobese Subjects J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4284 - 4288. [Abstract] [Full Text]

				S. Matetzky, D. Freimark, P. Chouraqui, I. Novikov, O. Agranat, B. Rabinowitz, E. Kaplinsky, and H. Hod The distinction between coronary and myocardial reperfusion after thrombolytic therapy by clinical markers of reperfusion J. Am. Coll. Cardiol., November 1, 1998; 32(5): 1326 - 1330. [Abstract] [Full Text] [PDF]

				D. J. Lanska and R. J. Kryscio In-hospital mortality following carotid endarterectomy Neurology, August 1, 1998; 51(2): 440 - 447. [Abstract] [Full Text] [PDF]

				R. L White Thrombolytic Therapy in Acute Myocardial Infarction Part II: 1997 Update Asian Cardiovasc Thorac Ann, March 1, 1998; 6(1): 03 - 10. [Abstract] [Full Text] [PDF]

				R. H. Christenson, E. M. Ohman, E. J. Topol, S. Peck, L. K. Newby, S.-H. Duh, D. J. Kereiakes, S. J. Worley, G. L. Alosozana, T. C. Wall, et al. Assessment of Coronary Reperfusion After Thrombolysis With a Model Combining Myoglobin, Creatine Kinase MB, and Clinical Variables Circulation, September 16, 1997; 96(6): 1776 - 1782. [Abstract] [Full Text]

				J. S. Reiner, C. F. Lundergan, A. Fung, K. Coyne, S. Cho, N. Israel, J. Kazmierski, G. Pilcher, J. Smith, S. Rohrbeck, et al. Evolution of Early TIMI 2 Flow After Thrombolysis for Acute Myocardial Infarction Circulation, November 15, 1996; 94(10): 2441 - 2446. [Abstract] [Full Text]

				M. J. Kern, J. A. Moore, F. V. Aguirre, R. G. Bach, E. A. Caracciolo, T. Wolford, A. F. Khoury, C. Mechem, and T. J. Donohue Determination of Angiographic (TIMI Grade) Blood Flow by Intracoronary Doppler Flow Velocity During Acute Myocardial Infarction Circulation, October 1, 1996; 94(7): 1545 - 1552. [Abstract] [Full Text]

				K. Iwakura, H. Ito, S. Takiuchi, Y. Taniyama, Y. Nakatsuchi, S. Negoro, Y. Higashino, A. Okamura, T. Masuyama, M. Hori, et al. Alternation in the Coronary Blood Flow Velocity Pattern in Patients With No Reflow and Reperfused Acute Myocardial Infarction Circulation, September 15, 1996; 94(6): 1269 - 1275. [Abstract] [Full Text]

				C. Bode, R. W. Smalling, G. Berg, C. Burnett, G. Lorch, J. M. Kalbfleisch, R. Chernoff, L. G. Christie, R. L. Feldman, A. A. Seals, et al. Randomized Comparison of Coronary Thrombolysis Achieved With Double-Bolus Reteplase (Recombinant Plasminogen Activator) and Front-Loaded, Accelerated Alteplase (Recombinant Tissue Plasminogen Activator) in Patients With Acute Myocardial Infarction Circulation, September 1, 1996; 94(5): 891 - 898. [Abstract] [Full Text]

				H. Ito, A. Okamura, K. Iwakura, T. Masuyama, M. Hori, S. Takiuchi, S. Negoro, Y. Nakatsuchi, Y. Taniyama, Y. Higashino, et al. Myocardial Perfusion Patterns Related to Thrombolysis in Myocardial Infarction Perfusion Grades After Coronary Angioplasty in Patients With Acute Anterior Wall Myocardial Infarction Circulation, June 1, 1996; 93(11): 1993 - 1999. [Abstract] [Full Text]

				C. W. White Simplicity's Virtue Scorned : Precision Comes to TIMI Flow Grading and the Results Are . . . Surprising Circulation, March 1, 1996; 93(5): 853 - 856. [Full Text]

				C. M. Gibson, C. P. Cannon, W. L. Daley, J. T. Dodge Jr, B. Alexander, S. J. Marble, C. H. McCabe, L. Raymond, T. Fortin, W. K. Poole, et al. TIMI Frame Count : A Quantitative Method of Assessing Coronary Artery Flow Circulation, March 1, 1996; 93(5): 879 - 888. [Abstract] [Full Text]

				F. P. Sarasin, H. Bounameaux, and J. Bogousslavsky Asymptomatic severe carotid stenosis: Immediate surgery or watchful waiting? A decision analysis Neurology, December 1, 1995; 45(12): 2147 - 2153. [Abstract] [Full Text] [PDF]

				T. Lenderink, M. L. Simoons, G.-A. Van Es, F. Van de Werf, M. Verstraete, and A. E.R. Arnold Benefit of Thrombolytic Therapy Is Sustained Throughout Five Years and Is Related to TIMI Perfusion Grade 3 But Not Grade 2 Flow at Discharge Circulation, September 1, 1995; 92(5): 1110 - 1116. [Abstract] [Full Text]

				R. W. Smalling, C. Bode, J. Kalbfleisch, S. Sen, P. Limbourg, F. Forycki, G. Habib, R. Feldman, S. Hohnloser, and A. Seals More Rapid, Complete, and Stable Coronary Thrombolysis With Bolus Administration of Reteplase Compared With Alteplase Infusion in Acute Myocardial Infarction Circulation, June 1, 1995; 91(11): 2725 - 2732. [Abstract] [Full Text]

				E. Geraci and G. Tognoni The Open Infarct-Related Artery Theory: A Critical View European Journal of Cardiovascular Prevention & Rehabilitation, December 1, 1994; 1(4): 301 - 309. [Abstract] [PDF]